[1]黄聪丽,王治新△.丹半汤治疗幽门螺旋杆菌相关性慢性非萎缩性胃炎临床研究[J].陕西中医,2019,(12):1709-1712.
　HUANG Congli,WANG Zhixin..Clinical research on treatment of chronic nonatrophic gastritis with HP infection by integrated Danban decoction[J].,2019,(12):1709-1712.
点击复制

丹半汤治疗幽门螺旋杆菌相关性慢性非萎缩性胃炎临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年12期
页码:
1709-1712
栏目:
临床研究
出版日期:
2019-12-05

文章信息/Info

Title:
Clinical research on treatment of chronic nonatrophic gastritis with HP infection by integrated Danban decoction
文章编号:
DOI:10.3969/j.issn.10007369.2019.12.014
作者:
黄聪丽1; 王治新2△
1.西安市第一医院中医科（西安710002）；2.陕西省神木市医院（神木719300）
Author(s):
HUANG Congli; WANG Zhixin.
Department of Traditional Chinese Medicine，Xi’an First Hospital(Xi’an 710002)
关键词:
幽门螺旋杆菌; 慢性非萎缩性胃炎; 丹半汤; 四联疗法
Keywords:
Key words Helicobacter pylor; Chronic nonatrophic gastritis; Danban decoction; Quadruple therapy
分类号:
R573.3
文献标志码:
A
摘要:
摘 要 目的：探讨采用丹半汤联合四联疗法治疗幽门螺旋杆菌感染引起的慢性非萎缩性胃炎的疗效。方法：选取60例慢性非萎缩性胃炎患者，随机分为两组，对照组和治疗组各30例。对照组患者给予阿莫西林胶囊、克拉霉素缓释片、奥美拉唑肠溶片、枸橼酸铋钾颗粒治疗，治疗组患者于上述四联疗法基础上联合中药汤剂丹半汤调理。治疗周期为21 d，治疗结束后分析两组患者根除HP疗效及中医症候改善情况。结果：治疗组中医症候疗效总有效率和临床痊愈率分别为9333%和36.67%；显著高于对照组的总有效率76.67%和临床痊愈率13.33%，差异均具有统计学意义（P＜001）。治疗组HP根除率63.33%，总有效率达86.67%；显著高于对照组HP根除率46.67%，总有效率为70.00%，差异均具有统计学意义(P＜001)。治疗后治疗组主症、次症积分较对照组均明显下降，两组症候积分具有明显的统计学意义(P＜001)。结论：丹半汤联合西药治疗HP相关性慢性非萎缩性胃炎的临床疗效优于单纯西药治疗。
Abstract:
Abstract Objective ：To investigate the effect of Danban decoction combined with quadruple therapy on Helicobacter pylori(HP) infection caused by chronic nonatrophic gastritis(CNAG) effect. Methods：Total of 60 patients with CNAG were divided into control group and treatment group according to the random number table method，30 cases in each group. The patients in the control group were treated with Amoxicillin capsules，Clarithromycin tablets，Omeprazole entericcoated tablets and Bismuth Potassium Citrate Granules as western medicine. The patients in the treatment group were given the same as the western medicine group,and Danban decoction. Treatment cycle were both 21 days.The efficacy of the two groups of patients were compared after the end of treatment. Results：The total effective rate was 93.33% and the clinical cure rate was 36.67% of patients in treatment group，which was better than that of the control group (76.67% and 13.33%)，with significant differences ((P＜001).The negative rate of HP of patients was 63.33% and the total effective rate was 86.67% in the treatment group,which was higher than that of the control group(46.67% and 70.00%)，with significant differences (P＜001).The integrals of primary symptom and minor symptom after treatment in treatment group were significantly lower than that of the control group ((P＜001). Conclusions:The combination of Danban decoction and quadruple therapy was better than the western medicine on the HPrelated CNAG .

参考文献/References:

[1] 刘永建.中西医结合治疗慢性胃炎合并HP感染患者的疗效观察[J].中西医结合心血管病电子杂志,2015,32(4):9697.
[2] 汪 荷，黄津芳，赵鸿雁，等.健康体检人群幽门螺旋杆菌感染状况调查[J]．中国卫生统计，2012，29(5)：734736．
[3] 张万岱.中医药治疗幽门螺杆菌感染的研究现状和展望\[A\].第二十三届全国中西医结合消化系统疾病学术会议暨消化疾病诊治进展学习班论文汇编\[C\].2011,1020.
[4] 胡伏莲，成 虹，张学智，等.多中心临床研究观察荆花胃康联合三联疗法治疗幽门螺旋杆菌相关性十二指肠溃疡和胃炎疗效及耐药分析町中华医学杂志，2012，92(10)：679684．
[5] 中华医学会消化病学分会.中国慢性胃炎共识意见(2017年，上海) [J].胃肠病学，2017,22(11):670687.
[6] 中国中西医结合学会消化系统疾病专业委员会.慢性非萎缩性胃炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志，2018,26 (1):18.
[7] 国家食品药品监督管理局. 中药新药临床研究指导原则(试行)[M]. 北京：中国医药科技出版社，2002：134139.
[8] 中华医学会消化病学分会幽门螺杆菌组. 第三次全国幽门螺杆菌感染若干问题[J]. 胃肠病学，2007，2 (6)：3238.
[9] Sugano K,Tack J,Kuipers EJ，et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut,2015,64(9):13531367.
[10] Miszczyk E，Hashash JG，Ehalabi M，et al. A randomized trial of standarddose versus halfdose rabeprazole，clarithromycin，and amoxicillin in the treatment of Helicobacter pylori infection[J]. Eur J Gastroenterol Hepatol，2011,23（5）:865870.
[11] 中华医学会消化病学分会幽门螺杆菌学组 / 全国幽门螺杆菌研究协作组 . 第四次全国幽门螺杆菌感染处理共识报告 [J]. 胃肠病学，2012，17(10)：618625.
[12] Graham DY，Lu H，Yamaoka Y. A report card to grade Helicobacter pylori therapy[J]. Helicobacter，2007，12(4)：275278.
[13] 王江源. 幽门螺旋杆菌根除治疗现状及影响因素分析 [J].中国现代医学杂志，2018，28(14)：8083.
[14] 徐 艺，叶 柏，单兆伟，等.中草药单味与复方对幽门螺旋杆菌抑制作用的实验研究[J]．中国中西医结合脾胃杂志，2008，8(5)：291293．
[15] 齐续林，高鹏飞,乔田奎，等．中药蒲公英抗肿瘤作用研究进展[J].中国肿瘤，2015，24(1)：5356．
[16] 王 红，田 明，王 淼，等．延胡索现代药理及临床研究进展[J].中医药学报，2010，38(6)：108111．
[17] 马丙祥，董宠凯．丹参的药理作用研究新进展[J]．中国药房，2014，25(7)：663665．

相似文献/References:

[1]唐丽萍,曾于恒,王容容,等.基于JAK2/STAT3信号通路探讨香仁胃舒汤治疗慢性非萎缩性胃炎大鼠机制[J].陕西中医,2022,(11):1501.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.003]
　TANG Liping,ZENG Yuheng,WANG Rongrong,et al.The mechanism of Xiangren Weishu decoction on chronic non-atrophic gastritis rats based on JAK2/STAT3 signaling pathway[J].,2022,(12):1501.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.003]

更新日期/Last Update: 2019-12-19